Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Tech Review.
Press releases published on July 14, 2025

U.S. Crypto Week Heralds Positive Turn — XY Miner Helps XRP and SOL Investors Increase Daily Yields
London, UK, July 14, 2025 (GLOBE NEWSWIRE) -- The "US Cryptocurrency Week" event held by the U.S. Congress has attracted much attention from global blockchain and digital asset investors. In a series of hearings and legislative proposals, many senators and …

SEALSQ Announces Pricing of $60.0 Million Registered Direct Offering
Geneva, Switzerland, July 14, 2025 (GLOBE NEWSWIRE) -- Offering to be led by Heights Capital Management, Inc., and will consist of ordinary shares sold at $4.00 per share, accompanied by warrants with an exercise price of $4.60. SEALSQ Corp (NASDAQ: LAES) …

Enovix Appoints Srikanth Kethu as Head of Enovix India to Accelerate Global Innovation and Regional Expansion
FREMONT, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Enovix”), a leader in advanced silicon battery technology, today announced the appointment of Srikanth Kethu as Head of Enovix India, effective today. In this key …

Impact Analytics Partners with KiK to Deliver AI-Optimized Planning, Merchandising, Inventory Management and More
NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Impact Analytics, the leader in AI-native planning, merchandising, inventory and pricing solutions for the retail, grocery, manufacturing and CPG industries, is proud to announce its partnership with German …

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase SCOTTSDALE, Ariz., July 14, 2025 (GLOBE NEWSWIRE) -- Journey …

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
July 14, 2025 Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a …

CompoSecure Enhances Board of Directors with the Appointment of Two Additional Independent Directors
SOMERSET, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced the appointment of two new members to its Board of Directors (“Board”). Effective …

Disc Medicine Appoints Nadim Ahmed to its Board of Directors
WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …

Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional extension to …

Unlock the Next Bitcoin‑Scale Boom with ABQuant’s BTCQuant Platform
Washington, D.C, July 14, 2025 (GLOBE NEWSWIRE) -- As Bitcoin surged over 300% between 2020 and 2023, digital assets have moved from speculative bets to a central pillar of modern finance. Billionaires like Elon Musk and Michael Saylor, and institutions …

Full Alliance Group Launches Qubitera Holdings, to Develop Quant Blockchain and YAHBEE Wallet for Healthcare and Web3
TAMPA, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group Inc. (OTC: FAGI) today announced the formation of Qubitera Holdings, Inc., a majority-owned subsidiary (80% ownership), created to lead the development of decentralized infrastructure and …

Endless Developer Grant Program Concludes First Stage, Crowns StarAI, Funmeta, and VDEP as Tier 1 Winners
London, UK, July 14, 2025 (GLOBE NEWSWIRE) -- At the Brunel Hack 25 - Blockchain Hackathon …

Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer
--Brian Hodous, Ph.D., promoted to chief scientific officer -- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical sciences and CMC -- Kristin Polsenski, M.B.A., expands role to include chief of staff to the CEO SAN DIEGO, July 14 …

MKS Inc. Announces Second Quarter 2025 Earnings Conference Call
ANDOVER, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release second quarter 2025 financial results after market close on …

JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)
IRVINE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating the …

LyondellBasell improves CDP climate score to A in 2024, strengthening ESG leadership
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced it has improved its climate change score from A-minus to A in CDP’s 2024 assessment, placing the company in the leadership category for the second consecutive year. CDP …

Applied Digital Sets Fiscal Fourth Quarter and Full Year 2025 Conference Call for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time
DALLAS, July 14, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (HPC) …

Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)
TORONTO, July 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultra-rare genetic diseases, today announced that Health …

Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)
TORONTO, 14 juill. 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ : RARE), une société biopharmaceutique spécialisée dans la mise au point et la commercialisation de nouveaux traitements contre des maladies génétiques rares et très rares, …

Rumble Names Ian O’Donnell VP for Rumble Cloud
LONGBOAT KEY, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced the hiring of Ian O’Donnell, a 20-year veteran of technology sales and marketing, as the company’s Vice …